Publications by authors named "Koen Wuyts"

Claim this Profile
T
Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients.
Alexandra-Roxana Ilie, Brendan T Griffin, Maria Vertzoni, Martin Kuentz, Filip Cuyckens, Koen Wuyts

Drug Dev Ind Pharm· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Montmorillonite-surfactant hybrid particles for modulating intestinal P-glycoprotein-mediated transport.
Rasmus Blaaholm Nielsen, Ariane Kahnt, Lieve Dillen, Koen Wuyts, Jan Snoeys

Int J Pharm· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo evaluation of different formulation strategies for sustained release injectables of a poorly soluble HIV protease inhibitor.
Joke Meeus, David J Scurr, Katie Amssoms, Koen Wuyts, Pieter Annaert

J Control Release· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood microsampling using capillaries for drug-exposure determination in early preclinical studies: a beneficial strategy to reduce blood sample volumes.
Lieve Dillen, Tine Loomans, Guy Van de Perre, Dries Versweyveld, Koen Wuyts

Bioanalysis· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of human oral plasma concentration-time profiles using preclinical data: comparative evaluation of prediction approaches in early pharmaceutical discovery.
An Van den Bergh, Vikash Sinha, Ron Gilissen, Roel Straetemans, Koen Wuyts

Clin Pharmacokinet· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121).
Jean-François Bonfanti, Christophe Meyer, Frédéric Doublet, Jérôme Fortin, Philippe Muller, Koen Wuyts

J Med Chem· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of a respiratory syncytial virus fusion inhibitor clinical candidate, part 1: improving the pharmacokinetic profile using the structure-property relationship.
Jean-François Bonfanti, Frédéric Doublet, Jérôme Fortin, Jean Lacrampe, Jérôme Guillemont, Koen Wuyts

J Med Chem· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New model for intravenous drug administration and blood sampling in the awake rat, designed to increase quality and throughput for in vivo pharmacokinetic analysis.
Claire Mackie, Koen Wuyts, Marc Haseldonckx, Saskia Blokland, Petra Gysemberg

J Pharmacol Toxicol Methods· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis